InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Call Matthew, Chief Operating Officer. Officer active across 2 companies, notably iTeos Therapeutics, Inc.. Cumulatively, 5 disclosures have been recorded. History available since 30 July 2021. The latest transaction was disclosed on 7 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
24,000 shares0Common StockSEC:0000950170-25-037520:0
44,000 shares0Common StockSEC:0000950170-23-068902:0
40,226 shares@ US$2.9529.1% of flowCommon StockSEC:0001209191-23-021566:0
53,672 shares@ US$2.9550.0% of flowCommon StockSEC:0001209191-21-050063:0
53,672 shares@ US$2.9535.4% of flowCommon StockSEC:0001209191-21-050063
5 of 5 declarations
About Call Matthew
Matthew Call serves as Chief Operating Officer of iTeos Therapeutics, Inc. He oversees the company's daily operations and ensures the efficiency of internal processes. Matthew plays a key role in implementing the business strategy and optimizing resources to support iTeos' growth.
